EUS ‐FNA of the Merkel cell carcinoma metastasis to the pancreas: Cytomorphology and immunocytochemistry on direct cytological smears
ConclusionIncreasing incidence of MCC warrants the inclusion of MCC in the differential diagnosis of tumours of small round blue cell morphology even in unusual sites. The cytomorphological features coupled with an ICC panel are usually enough to make a confident diagnosis of MCC. EUS‐FNA is a minimally invasive technique which enables sampling adequate tissue for all the ancillary methods eventually needed to support the diagnosis.
Publication date: Available online 30 May 2020Source: Pathology - Research and PracticeAuthor(s): Wenjing Qi, Chang Shi, Pengxin Zhang, Lu Feng, Junying Wang, Dan Chen
Publication date: Available online 30 May 2020Source: Gynecologic Oncology ReportsAuthor(s): Anya Laibangyang, Raanan Alter, Yasmin Hasan, S. Diane Yamada
Publication date: Available online 30 May 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Leticia Alvarez-Sarrado, Carlos De Bonrostro-Torralba, Andrea Espiau-Romera, Marta Benito-Vielba, Ana Lasierra-Beamonte, Jose Manuel Campillos-Maza
Publication date: Available online 30 May 2020Source: Annals of Medicine and SurgeryAuthor(s): Nariman Khan, Andrew Donati, Collin Clay
Publication date: Available online 30 May 2020Source: The Journal of Prosthetic DentistryAuthor(s): Christian Wesemann, Henriette Kienbaum, Magdalena Thun, Benedikt C. Spies, Florian Beuer, Axel Bumann
Publication date: June 2020Source: American Journal of Orthodontics and Dentofacial Orthopedics, Volume 157, Issue 6Author(s): Jin-Ho Park, Chung-Ju Hwang, Yoon-Jeong Choi, Khosrow Siamak Houschyar, Jae-Hun Yu, So-Yeon Bae, Jung-Yul Cha
Publication date: Available online 15 May 2020Source: Journal of Ginseng ResearchAuthor(s): Sirui Zhu, Xiaoli Liu, Mei Xue, Yu Li, Danhong Cai, Shijun Wang, Liang Zhang
Publication date: Available online 30 May 2020Source: Seminars in Cancer BiologyAuthor(s): Xiaohua Lu, Thomas Efferth
Publication date: Available online 30 April 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Alessandra Malato, Elena Rossi, Mario Tiribelli, Francesco Mendicino, Novella Pugliese
Authors: Dietz A, Wichmann G, Kuhnt T, Wiegand S Abstract Patients with locoregionally advanced laryngeal and hypopharyngeal squamous cell carcinomas (LHSCC) comprise two broad groups: those who are candidates for functional larynx preservation (LP) with avoidance of ablative surgery and those who are not. Currently, treatment depends on the patient's needs and wishes, the experience and recommendation of the surgeon, the philosophy of the institution, etc. The milestone VA trial established non-surgical LP in advanced LHSCC in the 1990s using induction chemotherapy (IC) with PF (cisplatin, P, plus 5‑fluorou...